Moreover, previous studies showed that METTL3 could elevate the stability of SOX2 by increasing its m6A level, thus contributing to the progression of glioma and colorectal cancer (Visvanathan et al., 2018; Li et al., 2019). Here, SOX2 is linked to central nervous system cancer.